A multivariate model for the meta-analysis of study level survival data at multiple times

被引:8
|
作者
Jackson, Dan [1 ]
Rollins, Katie [2 ]
Coughlin, Patrick [2 ]
机构
[1] MRC, Biostat Unit, Cambridge CB2 2BW, England
[2] Addenbrookes Hosp, Dept Vasc Surg, Cambridge, England
基金
英国医学研究理事会;
关键词
Bayesian modelling; critical leg ischemia; multivariate meta-analysis; survival analysis; random effects models; NETWORK METAANALYSIS; HETEROGENEITY; IMPACT;
D O I
10.1002/jrsm.1112
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Motivated by our meta-analytic dataset involving survival rates after treatment for critical leg ischemia, we develop and apply a new multivariate model for the meta-analysis of study level survival data at multiple times. Our data set involves 50 studies that provide mortality rates at up to seven time points, which we model simultaneously, and we compare the results to those obtained from standard methodologies. Our method uses exact binomial within-study distributions and enforces the constraints that both the study specific and the overall mortality rates must not decrease over time. We directly model the probabilities of mortality at each time point, which are the quantities of primary clinical interest. We also present I-2 statistics that quantify the impact of the between-study heterogeneity, which is very considerable in our data set. (c) 2014 The Authors. Research Synthesis Methods published by John Wiley & Sons, Ltd.
引用
收藏
页码:264 / 272
页数:9
相关论文
共 50 条
  • [31] Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
    Riley, Richard D.
    Jackson, Dan
    Salanti, Georgia
    Burke, Danielle L.
    Price, Malcolm
    Kirkham, Jamie
    White, Ian R.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 358 : j3932
  • [32] Survival meta-analysis of individual patient data and survival meta-analysis of published (aggregate) data - Is there an intermediate approach between these two opposite options?
    Messori, A
    Trippoli, S
    Vaiani, N
    Cattel, F
    CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 309 - 316
  • [33] NETWORK META-ANALYSIS OF INDIVIDUAL AND AGGREGATE LEVEL DATA
    Jansen, J. P.
    Cope, S.
    VALUE IN HEALTH, 2012, 15 (04) : A159 - A159
  • [34] Network meta-analysis of individual and aggregate level data
    Jansen, Jeroen P.
    RESEARCH SYNTHESIS METHODS, 2012, 3 (02) : 177 - 190
  • [35] EXTENDING MULTIVARIATE NETWORK META-ANALYSIS OF SURVIVAL FUNCTION PARAMETERS TO FRACTIONAL POLYNOMIALS
    Chan, K.
    Ayers, D.
    Jansen, J.
    Cope, S.
    VALUE IN HEALTH, 2020, 23 : S472 - S472
  • [36] Computing within-study covariances, data visualization, and missing data solutions for multivariate meta-analysis with metavcov
    Lu, Min
    FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [37] Maintenance Treatment with Interferon in Multiple MyelomaA Survival Meta-Analysis
    Sabrina Trippoli
    Paola Becagli
    Andrea Messori
    Enrico Tendi
    Clinical Drug Investigation, 1997, 14 : 392 - 399
  • [38] Maintenance treatment with interferon in multiple myeloma - A survival meta-analysis
    Trippoli, S
    Becagli, P
    Messori, A
    Tendi, E
    CLINICAL DRUG INVESTIGATION, 1997, 14 (05) : 392 - 399
  • [39] Meta-analysis of multiple treatment comparisons reported at multiple follow-up times
    Lu, G
    Ades, AE
    Sutton, AJS
    Cooper, NJ
    Briggs, AH
    VALUE IN HEALTH, 2005, 8 (06) : A123 - A124
  • [40] Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model
    Snell, Kym I. E.
    Hua, Harry
    Debray, Thomas P. A.
    Ensor, Joie
    Look, Maxime P.
    Moons, Karel G. M.
    Riley, Richard D.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 69 : 40 - 50